Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Contraction-released may sustain and delay muscle recovery

In some aging humans with , contraction-released could sustain new despite early . Sensitive tests finding no preceding or no less injury after would constrain this mechanism in the tested and window.

Omega Point 1.5

Stage of verification

  1. Hypothesis published2026-10-10
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionMuscles, bones and joints

Biological function

Muscle contraction generates force for physical work, including during exertion.Muscle contraction and force

Direction

Kind of knowledge gap

The question is designed to try to disprove the leading explanation.Adversarial gap

A double ring marks the main placement where a group contains several values.

Lens
Catalytic damage propagation
Goal
Накопление возрастных потерь при наложении незавершённых циклов восстановления
Competing hypotheses
3
Published
2026-10-10
Engine version
Omega Point 1.5
As a hypothesis
8 / 10Clarity of mechanism
8 / 10Few extra conditions
9 / 10Completeness of the answer
5 / 10Novelty of the idea
8 / 10Few new entities
7 / 10Decisive experiment
3 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Metabolite or ion

    An iron associated with that can be

    Where this hypothesis actsAfter contraction in aging humans with ;

    Hypotheses on this target 1
    Heme-associated ironSupplementation. Hypotheses on this target 0Accelerated excretion. Hypotheses on this target 0Composition restoration. Hypotheses on this target 0
    • Supplementation
    • Accelerated excretion
    • Composition restoration

    What is proposed

    Suppress the catalytic activity of the implicated

    With whatNot stated in the record

    HowConditional with confirmed -level ; no selective method is supplied. Assess direct effects on contraction, and

    Possible result

    Possible reduction in subsequent oxidative injury, delayed force loss and incomplete recovery

    From the recordan ordinary contraction could release a localized, catalytically available heme-associated iron pool that initiates lipid radical propagation

  2. Metabolism and energy

    Lipid peroxidation

    A process involving -chain that can cause persistent cellular injury

    Where this hypothesis actsFollowing an initiating contraction in ;

    Hypotheses on this target 7
    Lipid peroxidationInhibition. Hypotheses on this target 44Activation. Hypotheses on this target 0Function preservation. Hypotheses on this target 0Supplementation. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Inhibition4
    • Activation
    • Function preservation
    • Supplementation
    • Feedback restoration
    • Direct measurement

    What is proposed

    Interrupt continuing after the initiating contraction

    HowConditional, independently acting with and off-target ; no selective chain- method is supplied

    Possible result

    Possible reduction in newly forming damage and subsequent force loss while retaining useful and

    From the recordConvergent sequestration and independently acting chain termination support attribution only after target engagement and direct off-target routes are examined, not simply because both rescue.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesInterleukin-11. Hypotheses on this target 5Interleukin-11Antibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGenotoxic microbial toxins. Hypotheses on this target 1Genotoxic microbial toxinsGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNTHeme-associated iron. Hypotheses on this target 1Heme-associated iron
GenesRetroelements. Hypotheses on this target 3RetroelementsExtrachromosomal DNA. Hypotheses on this target 2Extrachromosomal DNAAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesGenomic alterations. Hypotheses on this target 1Genomic alterationsHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p300PCMT1. Hypotheses on this target 2PCMT1TIM-4. Hypotheses on this target 2TIM-412-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIContractile proteins. Hypotheses on this target 1Contractile proteinsDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenasegp130. Hypotheses on this target 1gp130HCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2IL-11 receptor alpha. Hypotheses on this target 1IL-11 receptor alphaInterleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6Talin. Hypotheses on this target 1TalinTLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsT cells. Hypotheses on this target 4T cellsEpithelial cells. Hypotheses on this target 3Epithelial cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueDamaged cells. Hypotheses on this target 2Damaged cellsMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsApoptotic bodies. Hypotheses on this target 1Apoptotic bodiesBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkConnective tissue. Hypotheses on this target 2Connective tissueSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCell-surface macromolecular brush. Hypotheses on this target 1Cell-surface macromolecular brushCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressExtracellular matrix mechanics. Hypotheses on this target 1Extracellular matrix mechanicsHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsMuscle fiber architecture. Hypotheses on this target 1Muscle fiber architectureSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 9EfferocytosisEpithelial barrier repair. Hypotheses on this target 7Epithelial barrier repairSensory afferent activity. Hypotheses on this target 7Sensory afferent activityProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 5Calcium phosphate mineral growthInflammatory response. Hypotheses on this target 5Inflammatory responseTissue renewal timing. Hypotheses on this target 5Tissue renewal timingAntigen presentation. Hypotheses on this target 4Antigen presentationAntigen-receptor signaling. Hypotheses on this target 4Antigen-receptor signalingInflammation resolution. Hypotheses on this target 4Inflammation resolutionVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentDNA repair. Hypotheses on this target 2DNA repairEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationMechanical loading. Hypotheses on this target 2Mechanical loadingOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTranscription. Hypotheses on this target 2TranscriptionTranscription–replication conflicts. Hypotheses on this target 2Transcription–replication conflictsTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportUbiquitin-dependent proteasomal degradation. Hypotheses on this target 2Ubiquitin-dependent proteasomal degradationAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCardiovascular feedback regulation. Hypotheses on this target 1Cardiovascular feedback regulationCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle alignment. Hypotheses on this target 1Cell-cycle alignmentCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell-cycle restraint coordination. Hypotheses on this target 1Cell-cycle restraint coordinationCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentriole duplication. Hypotheses on this target 1Centriole duplicationCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCortisol inactivation. Hypotheses on this target 1Cortisol inactivationCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHeterotypic cell replacement. Hypotheses on this target 1Heterotypic cell replacementHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLactate-to-glucose recycling. Hypotheses on this target 1Lactate-to-glucose recyclingLipid-dependent receptor signaling. Hypotheses on this target 1Lipid-dependent receptor signalingLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal exocytosis. Hypotheses on this target 1Lysosomal exocytosisLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkNuclear-envelope rupture. Hypotheses on this target 1Nuclear-envelope ruptureNuclear rejuvenation. Hypotheses on this target 1Nuclear rejuvenationNutrient uptake and metabolism. Hypotheses on this target 1Nutrient uptake and metabolismOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismOxygen delivery. Hypotheses on this target 1Oxygen deliveryParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPathogen production. Hypotheses on this target 1Pathogen productionPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPotassium uptake. Hypotheses on this target 1Potassium uptakePreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRepair-initiation signaling. Hypotheses on this target 1Repair-initiation signalingRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSodium reabsorption. Hypotheses on this target 1Sodium reabsorptionSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionLipid peroxidation. Hypotheses on this target 7Lipid peroxidation
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Muscle strength might return during rehabilitation while the conditions for another loss remain. The unexpected move is to borrow from the chemistry of corrosion: ordinary muscle activity could release an iron-containing substance that keeps damaging muscle after the activity ends. This is a proposal generated by the pipeline, not a measured result, and its suggested relevance is to some older people who tolerate exertion poorly after an infection.

The proposed mechanism, link by link
  1. Ordinary muscle contraction is proposed to release a local, .
  2. The released is proposed to start damaging reactions in nearby fats.
  3. A brief initiating event is proposed to become continuing formation of new damage after contraction ends, rather than leave only old damage behind.
  4. Continuing chemical damage is proposed to injure muscle despite genuine early improvement in capacity.
  5. That injury is proposed to cause delayed strength loss and incomplete recovery; interrupting the chemistry would help only if it materially contributes to those .
A picture for it

A spark can go out while a fire keeps consuming fresh material. Ash left behind is different from a fire that is still burning.

Where the picture breaks: The proposed muscle chemistry is not combustion. Continuing damage might still require repeated outside triggers, and the supplied material does not establish that the reaction can sustain itself after those triggers stop.

  1. Master questionstep 01 of 04

    Human aging is the target of a search for ways to slow it radically.

    Rests on: The supplied goal sets radical slowing of human aging as the desired outcome; it does not specify a mechanism.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Age-related losses are proposed to accumulate when another recovery cycle begins before the previous one finishes.

    Rests on: The aging goal supplies the outcome of interest, but does not establish overlapping, incomplete recovery as a cause.

    Assumption

    The chain takes accumulation through unfinished recovery cycles as a candidate explanation of aging; the supplied material does not establish that general relationship.

  3. Gap questionstep 03 of 04

    Rehabilitation might restore , the capacity available to meet physical demands, yet accelerate later functional loss in older people with poor exertion tolerance after infection. That outcome would challenge the prediction that reversing , the loss of capacity associated with reduced activity, completes recovery.

    Rests on: The preceding stage supplies the distinction between apparent improvement and unfinished recovery. It does not supply the choice of population or the prediction that reversing reduced-activity losses should complete recovery.

    Assumption

    The chain assumes this population and rehabilitation provide a useful setting for examining unfinished recovery. It does not establish that rehabilitation actually accelerates subsequent loss.

  4. Hypothesisstep 04 of 04

    Ordinary contraction could release a local , a substance that promotes chemical reactions, despite genuine early gains in capacity. It could initiate , a chain reaction in which reactive molecules pass damage between fats, and continuing damage could delay recovery and reduce strength later.S8

    Rests on: The preceding question supplies the puzzle of restored capacity followed by later loss. The corrosion analogy supplies a proposed explanation, while S8 supplies a narrower chemical basis: its 2023 review describes promoting , chemical reactions that can damage cell fats, after enters a . It does not establish release during contraction, continuing damage afterward, or functional loss in the proposed human population.

    Supported by literature

What is carried, and what is not. Of the five proposed mechanism links listed here, screened literature directly supports part of one: S8 describes promoting fat in its 2023 review, but does not establish the muscle-activity trigger or later human functional loss. S9, a 2020 Frontiers in Oncology review, describes related reactions involving iron released from , and S10, a 2022 Frontiers in Molecular Biosciences review, reports iron accumulation and fat damage after exhaustive exercise in mice; neither establishes the proposed iron , the ordinary-activity setting, or the complete sequence in older humans.S8S9S10

Where the reasoning is carried by something unstated · 2
  • Goal pillar. The chain takes accumulation through unfinished recovery cycles as a candidate explanation of aging; the supplied material does not establish that general relationship.
  • Gap question. The chain assumes this population and rehabilitation provide a useful setting for examining unfinished recovery. It does not establish that rehabilitation actually accelerates subsequent loss.
How a result here could mislead · 3
  • Sample collection could release iron or create fat damage, making laboratory handling look like a contraction-triggered event inside muscle. Measuring total iron could also mistake an unrelated iron for the proposed . What closes it: Samples require , that reveal contamination or handling effects, and independent of the chemical forms present. The work must distinguish still held in protein, released -associated , and iron subsequently separated from , while preserving their original location and chemical state. The supplied material does not establish that this preservation is feasible.
  • Damage remaining after contraction could be mistaken for continuing damage formation. Even newly forming damage could reflect repeated triggers from infection, inflammation, disrupted muscle structures, or other ongoing injury rather than a self-sustaining chemical process. What closes it: New damage formation and removal of existing must be measured separately. A defined period after contraction and an explicit model of reaction rates must bound continuing triggers, including chemical recycling within the proposed process. No duration or numerical bound is supplied. Without that separation, the evidence could support chemistry that amplifies continuing injury, but could not an .
  • An could preserve strength by reducing muscle work or directly changing energy use, infection, or immune , and that protection could be credited to the proposed . Conversely, failure to protect could be mistaken for failure of the hypothesis when the never reached or altered its target. What closes it: The intended must be shown to change in the relevant location, followed by reduced new before later injury and strength . Comparisons require documented activity, , living tissue amount, strength, injury and infection before , with comparable subsequent where feasible and for direct alternative actions. Later improvements caused by chemical protection must remain part of the measured benefit. No selective method is supplied, and lower damage-product levels alone would not establish functional protection.

What would make this wrong. The specified mechanism would be undermined by sufficiently sensitive measurements, with the relevant chemical state preserved, showing that the proposed available -associated does not rise before new fat damage, or that no continuing new damage occurs in the specified location and period. Its claimed contribution to functional loss would be undermined if selective, verified interruption reduced that new damage without reducing subsequent injury, strength loss or recovery delay under comparable . Dependence on continuing outside triggers would reject the autonomous version while leaving an injury-amplifying role possible. Such negative results would constrain the tested location and period, not establish a rival explanation.

What it would change. If the proposal held, restored strength alone would not establish completed recovery in the affected population: ongoing chemical injury could contribute to the next loss. Efforts to prevent accumulating loss would therefore need to distinguish rebuilt capacity from of damaging chemistry. That would not establish that interrupting this process radically slows human aging, that it applies beyond the identified population and tissue, or that it excludes defective replacement proteins, mechanically linked failures, or renewed production as causes.

Sources read · 7

10 literature searches, 5 full texts, 5 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S4BackgroundAbstract only

Induction of heme oxygenase-1 (HSP32) mRNA in skeletal muscle following contractions. · The American journal of physiology · 1997

“Increases in HSP32 mRNA may underlie an inducible antioxidant pathway in muscle responsive to metabolic stresses associated with repeated muscle contractions.”

Does not settle: The source does not establish contraction-induced release of catalytically available heme-associated iron, its species, accessibility or compartment; lipid radical initiation or continued propagation; delayed functional loss or incomplete recovery; effects in aging humans with postinfectious exertional intolerance; or whether interrupting this chemistry improves SPV_4 or SPV_5.

S5BackgroundAbstract only

Post-acute infection syndromes(PAIS): Hypothesis on the pathophysiological role of endogenously produced carbon monoxide · 2025

“This hypothesis posits that chronically elevated endogenous production of carbon monoxide (CO), primarily through the enzyme heme oxygenase-1 (HO-1), is a previously underappreciated cause of these syndromes.”

Does not settle: The abstract does not establish contraction-released heme-associated iron, its chemical species, accessibility or compartment; lipid-radical initiation or propagation; delayed muscle damage or recovery; effects in aging humans with postinfectious exertional intolerance; or whether safely interrupting this proposed chemistry improves SPV_4 or SPV_5.

S6BackgroundAbstract only

Post-Acute Infection Syndrome (PAIS): A hypothesis on invisible hypoxia caused by endogenous carbon monoxide · 2025

“This hypothesis posits that chronically elevated endogenous production of carbon monoxide (CO), primarily through the enzyme heme oxygenase-1 (HO-1), is a previously underappreciated cause of these syndromes.”

Does not settle: The abstract does not establish contraction-released heme-associated iron, its species, accessibility or compartment; lipid-radical initiation or continued propagation; delayed muscle damage or recovery; effects in aging humans with postinfectious exertional intolerance; or whether interrupting such chemistry improves SPV_4 or SPV_5.

S7BackgroundAbstract only

Post-Acute Infection Syndrome (PAIS): A hypothesis on invisible hypoxia caused by endogenous carbon monoxide · 2025

“This hypothesis posits that chronically elevated endogenous production of carbon monoxide (CO), primarily through the enzyme heme oxygenase-1 (HO-1), is a previously underappreciated cause of these syndromes.”

Does not settle: The abstract does not establish contraction-released heme-associated iron, its species, accessibility or compartment; lipid-radical initiation or continued chain propagation; delayed muscle damage or recovery in aging humans; or whether interrupting that chemistry improves SPV_4 or SPV_5.

S8Partly answers it

Heme: The Lord of the Iron Ring · Antioxidants · 2023

“Once heme has intercalated into the membrane, the iron in it can catalyze the oxidation of cell membrane lipids, leading to the formation of lipid peroxides.”

Does not settle: The source does not establish contraction-triggered heme release, a localized catalytically available pool in skeletal muscle, radical-chain propagation after contraction, delayed functional loss or incomplete recovery, effects in aging humans with postinfectious exertional intolerance, or improvement in SPV_4 and SPV_5 after a safe intervention.

S9Background

The Multifaceted Role of Heme in Cancer · Frontiers in Oncology · 2020

“LOOH is then broken down by the iron released by heme to produce free radicals and, subsequently, aldehyde molecules like malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) ( ).”

Does not settle: The source does not establish contraction-triggered heme release in skeletal muscle, a localized catalytically available heme-associated iron pool in aging humans with postinfectious exertional intolerance, continuing post-contraction radical propagation, delayed functional loss, incomplete recovery, or effects on SPV_4 and SPV_5.

S10Partly answers it

Ferroptosis and its role in skeletal muscle diseases · Frontiers in Molecular Biosciences · 2022

“The experimental data showed that there were characteristics related to ferroptosis in skeletal muscle of EEIF mice, such as accumulation of iron, lipid peroxide, decreased expression of GPX4 and GSH, suggesting that ferroptosis may participate in the process of EEIF disease ( ).”

Does not settle: The source does not establish an ordinary-contraction-triggered, localized catalytically available heme-associated iron pool; continuing radical-chain propagation after contraction; delayed functional loss or incomplete recovery; or effects in aging humans with postinfectious exertional intolerance. The cited exercise evidence concerns exhaustive exercise in mice and does not identify the iron species, accessibility, compartment, timescale, causal ordering, or effects on SPV_4 and SPV_5.

The gap this hypothesis explains

Two live hypotheses pull in opposite directions here, and the field has not chosen between them.

Does rehabilitation restore capacity yet accelerate later decline in older people whose symptoms worsen with exertion after infection?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Does rehabilitation that restores nevertheless accelerate subsequent functional loss in aging humans with , contradicting the prediction that reversing closes the recovery cycle?

What this question is asking

The question concerns whether improving a person's measured physical capacity can coexist with faster subsequent loss of everyday abilities. It asks about rehabilitation in aging humans with , meaning difficulty tolerating activity after an infection, including worsening symptoms following effort. The proposed sequence is that rehabilitation first restores , or capacity available beyond ordinary demands, but returning to ordinary activity then produces progressively longer recovery, greater effort for the same tasks, or lasting loss of capacity. Establishing acceleration would require a comparison showing that later function declines faster because of rehabilitation, rather than simply showing that some symptoms remain. The question assumes that reversing should otherwise close the recovery cycle, meaning that repeated activity and recovery stop leaving accumulating losses.

What the terms mean
Rehabilitation
Care intended to improve or recover functioning. It includes different combinations of treatments, so findings about one programme do not automatically describe all rehabilitation.
Measured reserve
Capacity available beyond what ordinary activities require. The question treats this as something rehabilitation can restore, but the supplied material does not provide a shared measurement or a criterion for full restoration.
Exercise capacity and exercise tolerance
How much physical effort a person can perform or sustain under specified conditions. These measurements can improve without establishing how reliably everyday activities can be repeated and recovered from.
Postinfectious exertional intolerance
Difficulty tolerating physical or mental effort after an infection, potentially including symptoms that worsen following activity. It describes a pattern of limitations rather than a single established cause.
Aging humans
The population named by the question, rendered as older people in the short question. The input specifies no age range and does not establish an aging-specific result.
Deconditioning
Loss of physical capacity associated with reduced activity. The question tests whether reversing this loss is enough to prevent repeated activity from producing accumulating limitations.
Recovery cycle
The question's model of activity followed by recovery. Closing the cycle means that successive ordinary activities stop producing progressively longer recovery, greater effort, or lasting capacity loss; it is not a validated measurement supplied by these sources.
Functional decline
Loss of ability to perform activities over time. Accelerated decline means a faster rate of loss relative to a relevant comparison, not simply a worse result on one occasion.
Persistent injury
Lasting damage, which the pipeline proposes might coexist with improved capacity. Symptoms or reduced performance alone do not establish such damage in the supplied evidence.
Peak oxygen consumption and aerobic capacity
Peak oxygen consumption is the highest rate of oxygen use measured during an exercise test. Aerobic capacity describes the capacity to sustain activity using oxygen-dependent energy production; both concern exercise performance rather than directly measuring lasting recovery.
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
A named illness involving substantial limitations and worsening symptoms after exertion. Its presence in several sources does not establish that their participants match the question's aging, postinfection population.
Post-exertional malaise
Worsening of symptoms following physical or mental effort. It concerns the response after activity, which may differ from the capacity measured during the activity itself.
Blood lactate
Lactate is a substance involved in how the body processes and transfers energy, and its concentration can be measured in blood during exercise. S6 reports changes in this measurement; those changes do not themselves establish persistent injury.
Maximal exercise test
A test intended to assess exercise performance near a person's maximum effort. Repeating such tests can reveal short-term changes after exertion, but does not by itself measure the consequences of repeated ordinary activity over longer periods.
Graded exercise therapy
An exercise-based treatment involving planned increases in activity over time. It is a particular treatment approach discussed by S4 and S10, rather than a synonym for every form of rehabilitation.
Cross-sectional design and survey association
A cross-sectional study examines participants without following the full sequence of changes required by this question. A survey association means reported experiences occur together; it does not by itself establish which event caused another.
What the question takes for granted
Premise only partly supported
Rehabilitation restores , and reversing is sufficient to close the recovery cycle so that ordinary activity does not progressively increase recovery time, relative effort, or loss.

Rehabilitation is care intended to improve functioning, and is a reduction in physical capacity associated with inactivity. The assumption is that rebuilding this capacity leaves enough capacity beyond everyday demands for repeated activity to stop producing accumulating losses. If that assumption held, restored capacity would be evidence that the process causing repeated loss had ended.

S2 reports improved maximal exercise tolerance, and S8 reports improvements in several measures of physical capacity and symptoms. These establish a narrower claim: selected can improve during rehabilitation. Neither establishes full restoration of or shows that those improvements prevent progressively worse recovery after ordinary activity. S1 reports incomplete recovery despite improved breathlessness and walking distance. The supplied sources therefore support improvement in selected , but do not establish the proposed sufficiency of reversing .S1S2S8

The same question asked without the part nothing read establishes:

  • In aging humans with symptoms that worsen after exertion following infection, does rehabilitation that improves measured physical capacity accelerate later loss of everyday function?
  • In this population, do improvements in measured physical capacity persist alongside stable recovery time and effort across repeated ordinary activities?
What turns on the answer
  • Capacity improves, but later decline accelerates If rehabilitation first restores measured capacity and causes a faster subsequent loss of everyday function, that restoration is insufficient to end the accumulating loss described by the question. Better exercise results could then coexist with worsening ability to sustain ordinary activity. This outcome alone would not the cause of the later loss or establish persistent injury.
  • Capacity improves and recovery remains stable If ordinary activity subsequently requires no progressively greater effort or recovery time and leaves no accumulating capacity loss, the observed pattern would fit the predicted recovery cycle. It would support lasting benefit over the period observed, although it would not by itself establish that reversing was the sole cause.
  • Capacity improves, but limitations persist without faster decline Some exercise measures could improve while symptoms or everyday limitations remain. That would show incomplete recovery, but would establish neither rehabilitation-caused acceleration of decline nor the predicted end of accumulating losses.
Why it matters

The proposed explanation starts with inactivity reducing physical capacity, which makes ordinary tasks consume a larger share of the capacity remaining. Rehabilitation would increase capacity, and the explanation predicts that ordinary tasks would consequently become easier to sustain and recover from. If restored capacity instead accompanies progressively worse recovery and faster loss of everyday function, an improved exercise result would not establish lasting recovery. Conversely, worsening after an exercise test or reported harm during rehabilitation does not by itself establish that rehabilitation first restored capacity and then caused faster decline. Confusing these sequences could misclassify either a temporary improvement as durable recovery or a short-term setback as evidence of accelerated long-term loss.

What is already established

RL-3 rehabilitation improves selected function; RL-2 intolerance findings challenge whether greater restored activity reliably ends the underlying loss process.

What would have to be true

Return to ordinary activity must not progressively increase recovery time, relative effort or loss across subsequent natural episodes.

What is missing

The promising rehabilitation mechanism fails as a sufficient explanation if restored coexists with greater persistent injury and later functional loss.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

SCOUT from and , unverified: In a subset of aging humans with , an ordinary contraction could release a localized, that initiates despite genuine early . Continued formation of after the initiating contraction could then cause delayed functional loss and incomplete recovery. The , and are part of the hypothesis: total iron, or cannot substitute for that . The remains an active with susceptible material and continuing , not merely persistent or generic . It could be an or a of mechanical, inflammatory or infectious injury; those versions require separation. A safe activity-preserving interruption could improve SPV_4 and SPV_5 only if the chemical injury materially drives them; neither effect nor their ordering is established.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

Under shared_conditions and the in competition_interpretation, an and : distinguish retained in protein, released -associated and any subsequent conversion to . No one substitutes for another; source, , concentration, and remain unknown. Conditional on their and , the implicated must precede newly forming and injury. Quantify formation separately from and follow new after contraction and before delayed force loss. Measure or bound fresh from inflammation, , , mechanical disruption and breakdown, together with and in the relevant . Operationally, the stronger autonomous version predicts continuing consequential new damage over a specified post- window after the initiating contraction ends and continuing external is absent or bounded too small to explain the under an explicit . Internal must be specified within that model rather than silently counted as zero . No duration or is supplied. If ongoing cannot be bounded or independently varied, is ; an remains possible. The ordinary alternative predicts continued insults or slowly cleared without the proposed preceding . For a future delayed interruption define t0 after the documented initiating history and before . Compare pre-t0 and , , force, injury, state and , then estimate the total subsequent protection from against its under a comparable independently schedule where feasible. Measure -level and new before subsequent injury and force change. Direct tool actions on , contraction, or growth that bypass the intended catalytic change are requiring specific if feasible; if unresolved, alone cannot attribute protection to the proposed . Changes after t0 in , injury, force, , inflammation or caused by chemical protection or belong to the and must not be . Do not require subsequent or injury equality to test preservation. A changed or direct is reported separately as an . A holding specified later infection or injury fixed concerns a narrower and is attempted only when independently feasible with ; it is not a prerequisite for the total amplifier effect. Convergent and independently acting support only after and direct are examined, not simply because both . must reproduce the identified , , concentration and timing; bulk toxic iron addition is not a . Relate the amount and duration of new to subsequent force loss and the fraction of recovery delay/, with useful and assessed. Lower without less injury or functional loss are insufficient. can a without or exclusion of mechanical/infectious causes. Adequate constrain the specified /window only and do not establish a rival.

States a measurable outcome; comparing rivals needs more conditions. The chunk predicts a conditional temporal ordering and continued new damage under stated conditions. These are measurable outcomes despite the missing duration and quantitative bound. Autonomy remains unidentified if ongoing initiation cannot be bounded or independently varied. No rival prediction was supplied. The chunk provides an explicit rejection condition: lower products alone are insufficient without reduced injury or functional loss. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Begin with , and independent in ethically obtained samples; collection can release iron or cause . must retain the and . must assess formation and as well as tissue force/ and inflammatory/mechanical injury. No selective , chain- or physiological restoration method is supplied. Assess relevant- , pre- and demand, and direct off-target , , growth and contraction before attributing . Follow later work, , force, infection and as potential effects or ; changes attributable to chemical protection are retained in the . No available means of separating those pathways or of bounding is assumed. If species cannot be preserved or selectively altered, evidence remains . These are conditional research tests, not human or regimens.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

Under shared_conditions and the in competition_interpretation, an and : distinguish retained in protein, released -associated and any subsequent conversion to . No one substitutes for another; source, , concentration, and remain unknown. Conditional on their and , the implicated must precede newly forming and injury. Quantify formation separately from and follow new after contraction and before delayed force loss. Measure or bound fresh from inflammation, , , mechanical disruption and breakdown, together with and in the relevant . Operationally, the stronger autonomous version predicts continuing consequential new damage over a specified post- window after the initiating contraction ends and continuing external is absent or bounded too small to explain the under an explicit . Internal must be specified within that model rather than silently counted as zero . No duration or is supplied. If ongoing cannot be bounded or independently varied, is ; an remains possible. The ordinary alternative predicts continued insults or slowly cleared without the proposed preceding . For a future delayed interruption define t0 after the documented initiating history and before . Compare pre-t0 and , , force, injury, state and , then estimate the total subsequent protection from against its under a comparable independently schedule where feasible. Measure -level and new before subsequent injury and force change. Direct tool actions on , contraction, or growth that bypass the intended catalytic change are requiring specific if feasible; if unresolved, alone cannot attribute protection to the proposed . Changes after t0 in , injury, force, , inflammation or caused by chemical protection or belong to the and must not be . Do not require subsequent or injury equality to test preservation. A changed or direct is reported separately as an . A holding specified later infection or injury fixed concerns a narrower and is attempted only when independently feasible with ; it is not a prerequisite for the total amplifier effect. Convergent and independently acting support only after and direct are examined, not simply because both . must reproduce the identified , , concentration and timing; bulk toxic iron addition is not a . Relate the amount and duration of new to subsequent force loss and the fraction of recovery delay/, with useful and assessed. Lower without less injury or functional loss are insufficient. can a without or exclusion of mechanical/infectious causes. Adequate constrain the specified /window only and do not establish a rival.

  • Rival 01 of 03
    Sequence errors in new muscle proteins may shorten their working life and cause later force loss

    Not yet published.

    What would separate them

    Sequence errors in new muscle proteins may shorten their working life and cause later force loss predicts: Under shared_conditions and the in competition_interpretation, excess independently confirmed in dated new must precede loss of function or removal of those same incorporated proteins and delayed force decline. Quantify by protein and , , , and subsequent . The is that the affected sites and amount, together with their contribution and loss, can account for a material part of beyond ; no universal or is assumed. Detection of a rare error alone does not establish consequential burden, and rarity alone does not exclude it: affected sites, and subsequent functional loss must determine relevance. First establish a feasible way to link the same error-bearing intact structures to initial mechanics and later fate; whole-muscle early gain alone does not do this. Distinguish force failure before removal from removal of still-competent material, , , , and measure the . If this cannot be established, retain that causal step as unverified. dates ; it does not or distinguish from . The ordinary alternative at the same initial states, imposed tolerated demands and times is abnormal , , or removal of during incomplete recovery without antecedent mechanically consequential sequence-error excess. Only if a and a sufficiently selective correction become feasible, define t0 before correction and compare the total subsequent effect of lower verified error production with the . Record pre-t0 , protein composition, /, , , history, , existing injury and competing causes, and use a comparable independently schedule where feasible. Verify error reduction before its proposed consequences. Assess direct tool effects on amount/composition, , , , force or that bypass error reduction; if they cannot be separated, any identifies only a , not a . In , changes after t0 in /, removal, , , or force caused by fewer errors are legitimate or of the and must not be . Measure their and distinguish them by time order and, only if feasible, or . A controlled direct-effect comparison fixing a specified history is an additional question only if with adequate and without introducing new injury; inability to fix it does not refute the total mechanism. Reduced or direct suppression of contraction is separately reported, not presented as . Existing erroneous material may need replacement, so immediate full recovery is not required. Normal at sufficient , and timing, with bounds excluding a burden capable of the observed loss, weakens this mechanism locally. through lower , chemistry or suppression can preserve defective material or remove an , and does not refute a or establish a different .

  • What would separate them

    Damaged connective-tissue paths may spread failure between otherwise capable muscle regions predicts: Under shared_conditions and the in competition_interpretation, map repeatable , and a named vulnerable before a . Define t0 immediately before that event, separately from any earlier . Record pre-event , , recovery intervals, , , and , and contemporaneous externally imposed common demand that is not generated by the event. Compare linked and unlinked regions with in those pre-event states and . The focal prediction is a localized followed by demonstrable mechanically transmitted change and persistent injury/force loss in otherwise capable linked regions. must separate from an independently traveling or disturbance. An ordered alone does not establish that separation. The ordinary alternative permits through common overload, incomplete recovery, marginal weakness or shared / without a . Equal and alone do not that alternative. The primary target is the of the demonstrated or, separately, of a feasible on later and . Event-generated of , stress concentration, or , and resulting changes in , are possible transmission ; they are measured after t0, not . No excess beyond all post-event local histories or is required for this . still requires adequate of pre-event and independent evidence of the named transmitted process; unexplained correlation is insufficient. A future noninjurious modification must first be validated in an , with and comparable pre- state and independently where feasible. Measure its direct effects on capacity, and , its effect on the /transmission, subsequent , achieved and . Protection caused by lower , or with no demonstrated , is a meaningful total result but does not alone this . Changes in generated by a demonstrated path effect remain part of that effect even without post-event exposure . A at fixed local histories is a distinct, optional requiring feasible independent and ; absence of either leaves that narrower rather than disproving total . Useful force retention, independence and absence of are separately required for an . Distinguish persistent structural/functional injury from . Lack of reproducible regions or the required vulnerable path weakens this particular import; a good , unexplained or a rival alone cannot or exclude it. Biochemical and infectious processes may lie or . For the conservative benefit scenario in process_hypothesis, assess later , , independence, and injury elsewhere as at the declared ordinary tasks across repeated episodes. A loading increase alone does not negate a demonstrated total path effect; any broader requires a net comparison of retained function and injury, with the individual reported separately. No acceptable numerical tradeoff or safe manipulation is supplied.

  • What would separate them

    Rebuilding after exertion may enable a tissue pathogen reservoir to produce new pathogens predicts: Under shared_conditions and the in competition_interpretation, first an organism and an anatomically constrained , with an organism/-specific on low or and a predeclared site/window. No organism, site or threshold is supplied. Demonstrate linkage of genuinely new to that same reservoir rather than another site or new exposure. A specified rebuilding-associated change must precede the rise, followed by local injury and delayed loss despite genuine early . Repeat this ordering across natural tolerated episodes and quantify output burden, recurrence, injury and functional magnitude. Organism-appropriate must distinguish from persistent , static , , , and fragments released after damage. The ordinary alternative at the same initial states, tolerated demands and times permits and fragments, already active or independently fluctuating infection, , or stress/ changes without rebuilding as a gate. Separate two causal questions. For the of suppressing demonstrated new , define t0 before suppression; compare pre-t0 reservoir/output history, rebuilding, /, inflammation, , mechanics, catalytic state, , force and work history, with comparable independently where feasible. Only after an observed transition, a and a sufficiently selective exist does reduced output followed by reduced new injury support infection-dependent protection. Direct drug effects on inflammation, , rebuilding, , mechanics, chemistry, or contraction that bypass output reduction must be assessed and separated where possible; otherwise a is only a . In , changes caused by lower infection in those same variables, including subsequent , and force, are intended or and are included in the total infection effect. Reduced inflammation or is compatible with infection causality, not a . Do not require post-suppression , mechanics, chemistry or force to remain equal. Controlled direct-effect fixing specified are additional questions only if independently feasible with . Record any changed imposed activity exposure separately. For the distinctive , output suppression alone is insufficient. A preparation must retain the same - transition. the proposed rebuilding change and, only if possible, selectively vary it before while comparing pre-gate stress, injury, , nutrient availability and baseline /organism capacity. Determine whether gate-associated changes act through an explicitly specified or are independently caused alternatives; measure their without automatically matching away any proposed gate . A manipulation merely reducing general or survival does not a . If rebuilding cannot be separated from its , keep the gate unverified even if infection-dependent injury is supported. must reproduce the same -state transition and organism; fragments or an unrelated imposed infection cannot validate it. Existing damage need not reverse immediately. A verified reduction in output without less new injury over an adequately sensitive constrains ongoing dependence locally, not all historical infection effects. Negative samples constrain the named organism, site, and window, not every reservoir and not a rival. , safe duration, after , and activity-preserving remain unknown.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.